Protocol for an evaluation of the initiation of an integrated longitudinal outpatient care model for severe chronic non-communicable diseases (PEN-Plus) at secondary care facilities (district hospitals) in 10 lower-income countries

Alma J Adler,Emily B Wroe,Andrea Atzori,Neusa Bay,Wondu Bekele,Victoria M Bhambhani,Remy Bitwayiki Nkwiro,Chantelle Boudreaux,Dawson Calixte,Jonathan Chiwanda Banda,Matthew M Coates,Wubaye Walelgne Dagnaw,Katia Domingues,Laura Drown,Symaque Dusabeyezu,Darius Fenelon,Neil Gupta,Isaac Ssinabulya,Yogesh Jain,Yogeshwar Kalkonde,Innocent Kamali,Catherine Karekezi,Biraj Man Karmacharya,Bhagawan Koirala,Julie Makani,Fabio Manenti,Alexio Mangwiro,Beatriz Manuel,Jones K Masiye,Fastone Mathew Goma,Mary Theodory Mayige,Amy McLaughlin,Emmanuel Mensah,Nicole Mocumbi Salipa,Reuben Mutagaywa,Alvern Mutengerere,Gedeon Ngoga,Marta Patiño,Giovanni Putoto,Todd Ruderman,Devashri Salvi,Santigie Sesay,Fameti Taero,Emílio Tostão,Sterman Toussaint,Gene Bukhman,Ana Olga Mocumbi

DOI: https://doi.org/10.1136/bmjopen-2023-074182

IF: 3.006

2024-01-01

BMJ Open

Abstract:Introduction The Package of Essential Noncommunicable Disease Interventions—Plus (PEN-Plus) is a strategy decentralising care for severe non-communicable diseases (NCDs) including type 1 diabetes, rheumatic heart disease and sickle cell disease, to increase access to care. In the PEN-Plus model, mid-level clinicians in intermediary facilities in low and lower middle income countries are trained to provide integrated care for conditions where services traditionally were only available at tertiary referral facilities. For the upcoming phase of activities, 18 first-level hospitals in 9 countries and 1 state in India were selected for PEN-Plus expansion and will treat a variety of severe NCDs. Over 3 years, the countries and state are expected to: (1) establish PEN-Plus clinics in one or two district hospitals, (2) support these clinics to mature into training sites in preparation for national or state-level scale-up, and (3) work with the national or state-level stakeholders to describe, measure and advocate for PEN-Plus to support development of a national operational plan for scale-up. Methods and analysis Guided by Proctor outcomes for implementation research, we are conducting a mixed-method evaluation consisting of 10 components to understand outcomes in clinical implementation, training and policy development. Data will be collected through a mix of quantitative surveys, routine reporting, routine clinical data and qualitative interviews. Ethics and dissemination This protocol has been considered exempt or covered by central and local institutional review boards. Findings will be disseminated throughout the project’s course, including through quarterly M&E discussions, semiannual formative assessments, dashboard mapping of progress, quarterly newsletters, regular feedback loops with national stakeholders and publication in peer-reviewed journals.

medicine, general & internal

What problem does this paper attempt to address?

This paper aims to evaluate the initiation of a comprehensive longitudinal outpatient care model named PEN - Plus (Package of Essential Noncommunicable Disease Interventions—Plus) in secondary - level medical institutions (district hospitals) in 10 low - income countries. PEN - Plus is a strategy aimed at increasing access to care for patients with these diseases by decentralizing the care of severe chronic non - communicable diseases such as type 1 diabetes, rheumatic heart disease, and sickle - cell disease. Specifically, the objectives of the study include:

1. **Establish PEN - Plus clinics**: Establish PEN - Plus clinics in one or two district hospitals in each participating country, with at least one of these clinics located in a rural area. The clinics will be staffed with trained personnel and will provide long - term care services for patients with severe or complex chronic non - communicable diseases.

2. **Support PEN - Plus clinics to mature into training bases**: Assist these clinics in developing into training bases in preparation for national or state - level promotion, and be able to receive PEN - Plus clinic trainees from other regions.

3. **Collaborate with national or state - level stakeholders**: Describe, measure, and advocate for PEN - Plus, support the development of a national PEN - Plus operational plan for national roll - out after the end of the project funding period.

The study uses a mixed - methods evaluation design, including multiple data collection methods such as quantitative surveys, routine reporting, routine clinical data collection, and qualitative interviews, to comprehensively understand the achievements of PEN - Plus in clinical implementation, training, and policy development. The main objective of the study is to evaluate the implementation effectiveness of PEN - Plus in new settings and its national - level scalability.